Statistics for Perspective Therapeutics, mmon Stock (id:170 CATX)

Valuation metrics

Market cap

583.62M

Enterprise value

339.30M

Trailing P/E (ttm)

-3.99

Forward P/E

-8.00

PEG ratio

-8.00

Price/Sales (ttm)

374.84

Price/Book (mrq)

1.78

Enterprise Value/Revenue

217.92

Enterprise Value/EBITDA

-6.08

Overview

Shares outstanding

67.43M

Float

43.46M

Shares short

8.02M

% Held by insiders

0.20%

% Held by institutions

0.81%

Average volume (10 days)

812.89K

Average volume (90 days)

Price summary

52-Week low

2.30

52-Week high

19.10

52-Week change

61.65%

Beta

1.47

50-Day moving average

12.70

200-Day moving average

12.82

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

June 17th, 2024

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-5,049.86%

Operational effectiveness

Return on assets

-14.35%

Return on equity

-27.02%

Income statement

Revenue (ttm)

0.03

Revenue per share (ttm)

0.03

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-55,762,000.00

Net income to common (ttm)

-57,712,000.00

Diluted EPS (ttm)

-1.47

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

267.85M

Total cash per share (mrq)

3.96

Total debt (mrq)

4.27M

Total Debt/Equity (mrq)

1.30

Current ratio (mrq)

960.00%

Book value per share (mrq)

4.86

Cash flow

Cash flow statement

-696,000.00

Levered free cash flow (LFCF)

-49,486,876.00